Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non‐small cell lung cancer patients treated with radiotherapy
Abstract Background The level of hemoglobin A1c (HbA1c) might be associated with the severity of tumor hypoxia in patients with cancer. Here, we evaluated the association between the level of HbA1c and survival outcome in stage III non‐small cell lung cancer patients treated with radical radiotherap...
Guardado en:
Autores principales: | Moonkyoo Kong, Yu Jin Lim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5c9b5ee6000452d9e939c41d589bf5f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Changes in pulmonary function tests in breast carcinoma patients treated with locoregional post-mastectomy radiotherapy: results of a pilot study
por: AlSaeed EF, et al.
Publicado: (2017) -
Factors associated with locoregional recurrence in penile cancer: a case-control study
por: Aldo Zárate-González, et al.
Publicado: (2021) -
Radiotherapy for Recurrent Keloid: A Case Report
por: Christina Hari Nawangsih Prihharsanti, et al.
Publicado: (2020) -
Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy
por: Min Kyu Kang, et al.
Publicado: (2021) -
Effect of statins on breast cancer recurrence and mortality: a review
por: Van Wyhe RD, et al.
Publicado: (2017)